Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test
The forced swimming test (FST) is a behavioral test in rodents that predicts the clinical efficacy of many types of antidepressant treatments. Recently, a behavior sampling technique was developed that scores individual response categories, including swimming, climbing and immobility. Although all a...
Gespeichert in:
Veröffentlicht in: | Psychopharmacologia 1999-11, Vol.147 (2), p.162-167 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 167 |
---|---|
container_issue | 2 |
container_start_page | 162 |
container_title | Psychopharmacologia |
container_volume | 147 |
creator | PAGE, Michelle E DETKE, Michael J DALVI, Ashutosh KIRBY, Lynn G LUCKI, Irwin |
description | The forced swimming test (FST) is a behavioral test in rodents that predicts the clinical efficacy of many types of antidepressant treatments. Recently, a behavior sampling technique was developed that scores individual response categories, including swimming, climbing and immobility. Although all antidepressant drugs reduce immobility in the FST, at least two distinct active behavioral patterns are produced by pharmacologically selective antidepressant drugs. Serotonin-selective reuptake inhibitors increase swimming behavior, while drugs acting primarily to increase extracellular levels of norepinephrine or dopamine increase climbing behavior. Distinct patterns of active behaviors in the FST may be mediated by distinct neurotransmitters, but this has not been shown directly.
The present study examined the role of serotonin in mediating active behaviors in the forced swimming test after treatment with two antidepressant drugs, the selective serotonin reuptake inhibitor, fluoxetine and the selective norepinephrine reuptake inhibitor, desipramine.
Endogenous serotonin was depleted by administering para-cholorophenylalanine (PCPA, 150 mg/kg, IP.) to rats 72 h and 48 h prior to the swim test. Fluoxetine (10 mg/kg, SC) or desipramine (10 mg/kg, SC) was given three times over a 24-h period prior to the FST. Behavioral responses, including immobility, swimming and climbing, were counted during the 5-min test.
Pretreatment with PCPA blocked fluoxetine-induced reduction in immobility and increase in swimming behavior during the FST. In contrast, PCPA pretreatment did not interfere with the ability of desipramine to reduce immobility and increase climbing behavior.
Depletion of serotonin prevented the behavioral effects of the selective serotonin reuptake inhibitor fluoxetine in the rat FST. Furthermore, depletion of serotonin had no impact on the behavioral effects induced by the selective norepinephrine reuptake inhibitor, desipramine. The effects of antidepressant drugs on FST-induced immobility may be exerted by distinguishable contributions from different neurotransmitter systems. |
doi_str_mv | 10.1007/s002130051156 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69346455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3117814666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-e0fd6ed1e890a171737665a25f8f43996128e8c7a095865a9a8db4f11a6dcd633</originalsourceid><addsrcrecordid>eNqF0c9vFCEUB3BibOy2evRqSGw8OfreMPyYo2lqNWnSg3qesMyj0swMKzBR_3vZ7ib-uMiFwPvwCHwZe47wBgH02wzQogCQiFI9YhvsRNu0oNvHbAMgRCNQmlN2lvM91NGZ7gk7RZA9GiM2LHyiFEtcKN0Fx2cagy0hLjx6Xr4SJ-_Jlbxf-mmNP6iEhV7z7Vr4EgsfKYddsvPDZlgejiRbuI_J0cjz9zDX2h0vlMtTduLtlOnZcT5nX95ffb780NzcXn-8fHfTOKF1aQj8qGhEMj1Y1KiFVkraVnrjO9H3CltDxmkLvTS10FszbjuPaNXoRiXEOXt16LtL8dtaLx7mkB1Nk10ornlQvehUJ-V_IWoldQuqwpf_wPu4pqU-YhCI2mCn1F41B-VSzDmRH3YpzDb9HBCGfVTDX1FV_-LYdd3Wf_9DH7Kp4OIIbHZ28skuLuTfTgrRdiB-ARWomgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3117814666</pqid></control><display><type>article</type><title>Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>PAGE, Michelle E ; DETKE, Michael J ; DALVI, Ashutosh ; KIRBY, Lynn G ; LUCKI, Irwin</creator><creatorcontrib>PAGE, Michelle E ; DETKE, Michael J ; DALVI, Ashutosh ; KIRBY, Lynn G ; LUCKI, Irwin</creatorcontrib><description>The forced swimming test (FST) is a behavioral test in rodents that predicts the clinical efficacy of many types of antidepressant treatments. Recently, a behavior sampling technique was developed that scores individual response categories, including swimming, climbing and immobility. Although all antidepressant drugs reduce immobility in the FST, at least two distinct active behavioral patterns are produced by pharmacologically selective antidepressant drugs. Serotonin-selective reuptake inhibitors increase swimming behavior, while drugs acting primarily to increase extracellular levels of norepinephrine or dopamine increase climbing behavior. Distinct patterns of active behaviors in the FST may be mediated by distinct neurotransmitters, but this has not been shown directly.
The present study examined the role of serotonin in mediating active behaviors in the forced swimming test after treatment with two antidepressant drugs, the selective serotonin reuptake inhibitor, fluoxetine and the selective norepinephrine reuptake inhibitor, desipramine.
Endogenous serotonin was depleted by administering para-cholorophenylalanine (PCPA, 150 mg/kg, IP.) to rats 72 h and 48 h prior to the swim test. Fluoxetine (10 mg/kg, SC) or desipramine (10 mg/kg, SC) was given three times over a 24-h period prior to the FST. Behavioral responses, including immobility, swimming and climbing, were counted during the 5-min test.
Pretreatment with PCPA blocked fluoxetine-induced reduction in immobility and increase in swimming behavior during the FST. In contrast, PCPA pretreatment did not interfere with the ability of desipramine to reduce immobility and increase climbing behavior.
Depletion of serotonin prevented the behavioral effects of the selective serotonin reuptake inhibitor fluoxetine in the rat FST. Furthermore, depletion of serotonin had no impact on the behavioral effects induced by the selective norepinephrine reuptake inhibitor, desipramine. The effects of antidepressant drugs on FST-induced immobility may be exerted by distinguishable contributions from different neurotransmitter systems.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s002130051156</identifier><identifier>PMID: 10591883</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Animals ; Antidepressants ; Antidepressive Agents - therapeutic use ; Behavior ; Biological and medical sciences ; Climbing ; Desipramine ; Desipramine - therapeutic use ; Drugs ; Extracellular levels ; Fenclonine ; Fluoxetine ; Fluoxetine - therapeutic use ; Male ; Medical sciences ; Motor Activity - drug effects ; Neuropharmacology ; Norepinephrine ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; selective norepinephrine reuptake inhibitors ; selective serotonin reuptake inhibitors ; Serotonin ; Serotonin - physiology ; Serotonin Antagonists ; Serotonin uptake inhibitors ; Stress, Physiological - drug therapy ; Swimming ; Swimming behavior</subject><ispartof>Psychopharmacologia, 1999-11, Vol.147 (2), p.162-167</ispartof><rights>2000 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1999.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-e0fd6ed1e890a171737665a25f8f43996128e8c7a095865a9a8db4f11a6dcd633</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1533240$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10591883$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PAGE, Michelle E</creatorcontrib><creatorcontrib>DETKE, Michael J</creatorcontrib><creatorcontrib>DALVI, Ashutosh</creatorcontrib><creatorcontrib>KIRBY, Lynn G</creatorcontrib><creatorcontrib>LUCKI, Irwin</creatorcontrib><title>Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology (Berl)</addtitle><description>The forced swimming test (FST) is a behavioral test in rodents that predicts the clinical efficacy of many types of antidepressant treatments. Recently, a behavior sampling technique was developed that scores individual response categories, including swimming, climbing and immobility. Although all antidepressant drugs reduce immobility in the FST, at least two distinct active behavioral patterns are produced by pharmacologically selective antidepressant drugs. Serotonin-selective reuptake inhibitors increase swimming behavior, while drugs acting primarily to increase extracellular levels of norepinephrine or dopamine increase climbing behavior. Distinct patterns of active behaviors in the FST may be mediated by distinct neurotransmitters, but this has not been shown directly.
The present study examined the role of serotonin in mediating active behaviors in the forced swimming test after treatment with two antidepressant drugs, the selective serotonin reuptake inhibitor, fluoxetine and the selective norepinephrine reuptake inhibitor, desipramine.
Endogenous serotonin was depleted by administering para-cholorophenylalanine (PCPA, 150 mg/kg, IP.) to rats 72 h and 48 h prior to the swim test. Fluoxetine (10 mg/kg, SC) or desipramine (10 mg/kg, SC) was given three times over a 24-h period prior to the FST. Behavioral responses, including immobility, swimming and climbing, were counted during the 5-min test.
Pretreatment with PCPA blocked fluoxetine-induced reduction in immobility and increase in swimming behavior during the FST. In contrast, PCPA pretreatment did not interfere with the ability of desipramine to reduce immobility and increase climbing behavior.
Depletion of serotonin prevented the behavioral effects of the selective serotonin reuptake inhibitor fluoxetine in the rat FST. Furthermore, depletion of serotonin had no impact on the behavioral effects induced by the selective norepinephrine reuptake inhibitor, desipramine. The effects of antidepressant drugs on FST-induced immobility may be exerted by distinguishable contributions from different neurotransmitter systems.</description><subject>Animals</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Behavior</subject><subject>Biological and medical sciences</subject><subject>Climbing</subject><subject>Desipramine</subject><subject>Desipramine - therapeutic use</subject><subject>Drugs</subject><subject>Extracellular levels</subject><subject>Fenclonine</subject><subject>Fluoxetine</subject><subject>Fluoxetine - therapeutic use</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Motor Activity - drug effects</subject><subject>Neuropharmacology</subject><subject>Norepinephrine</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>selective norepinephrine reuptake inhibitors</subject><subject>selective serotonin reuptake inhibitors</subject><subject>Serotonin</subject><subject>Serotonin - physiology</subject><subject>Serotonin Antagonists</subject><subject>Serotonin uptake inhibitors</subject><subject>Stress, Physiological - drug therapy</subject><subject>Swimming</subject><subject>Swimming behavior</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqF0c9vFCEUB3BibOy2evRqSGw8OfreMPyYo2lqNWnSg3qesMyj0swMKzBR_3vZ7ib-uMiFwPvwCHwZe47wBgH02wzQogCQiFI9YhvsRNu0oNvHbAMgRCNQmlN2lvM91NGZ7gk7RZA9GiM2LHyiFEtcKN0Fx2cagy0hLjx6Xr4SJ-_Jlbxf-mmNP6iEhV7z7Vr4EgsfKYddsvPDZlgejiRbuI_J0cjz9zDX2h0vlMtTduLtlOnZcT5nX95ffb780NzcXn-8fHfTOKF1aQj8qGhEMj1Y1KiFVkraVnrjO9H3CltDxmkLvTS10FszbjuPaNXoRiXEOXt16LtL8dtaLx7mkB1Nk10ornlQvehUJ-V_IWoldQuqwpf_wPu4pqU-YhCI2mCn1F41B-VSzDmRH3YpzDb9HBCGfVTDX1FV_-LYdd3Wf_9DH7Kp4OIIbHZ28skuLuTfTgrRdiB-ARWomgA</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>PAGE, Michelle E</creator><creator>DETKE, Michael J</creator><creator>DALVI, Ashutosh</creator><creator>KIRBY, Lynn G</creator><creator>LUCKI, Irwin</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19991101</creationdate><title>Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test</title><author>PAGE, Michelle E ; DETKE, Michael J ; DALVI, Ashutosh ; KIRBY, Lynn G ; LUCKI, Irwin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-e0fd6ed1e890a171737665a25f8f43996128e8c7a095865a9a8db4f11a6dcd633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Behavior</topic><topic>Biological and medical sciences</topic><topic>Climbing</topic><topic>Desipramine</topic><topic>Desipramine - therapeutic use</topic><topic>Drugs</topic><topic>Extracellular levels</topic><topic>Fenclonine</topic><topic>Fluoxetine</topic><topic>Fluoxetine - therapeutic use</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Motor Activity - drug effects</topic><topic>Neuropharmacology</topic><topic>Norepinephrine</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>selective norepinephrine reuptake inhibitors</topic><topic>selective serotonin reuptake inhibitors</topic><topic>Serotonin</topic><topic>Serotonin - physiology</topic><topic>Serotonin Antagonists</topic><topic>Serotonin uptake inhibitors</topic><topic>Stress, Physiological - drug therapy</topic><topic>Swimming</topic><topic>Swimming behavior</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PAGE, Michelle E</creatorcontrib><creatorcontrib>DETKE, Michael J</creatorcontrib><creatorcontrib>DALVI, Ashutosh</creatorcontrib><creatorcontrib>KIRBY, Lynn G</creatorcontrib><creatorcontrib>LUCKI, Irwin</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PAGE, Michelle E</au><au>DETKE, Michael J</au><au>DALVI, Ashutosh</au><au>KIRBY, Lynn G</au><au>LUCKI, Irwin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test</atitle><jtitle>Psychopharmacologia</jtitle><addtitle>Psychopharmacology (Berl)</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>147</volume><issue>2</issue><spage>162</spage><epage>167</epage><pages>162-167</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>The forced swimming test (FST) is a behavioral test in rodents that predicts the clinical efficacy of many types of antidepressant treatments. Recently, a behavior sampling technique was developed that scores individual response categories, including swimming, climbing and immobility. Although all antidepressant drugs reduce immobility in the FST, at least two distinct active behavioral patterns are produced by pharmacologically selective antidepressant drugs. Serotonin-selective reuptake inhibitors increase swimming behavior, while drugs acting primarily to increase extracellular levels of norepinephrine or dopamine increase climbing behavior. Distinct patterns of active behaviors in the FST may be mediated by distinct neurotransmitters, but this has not been shown directly.
The present study examined the role of serotonin in mediating active behaviors in the forced swimming test after treatment with two antidepressant drugs, the selective serotonin reuptake inhibitor, fluoxetine and the selective norepinephrine reuptake inhibitor, desipramine.
Endogenous serotonin was depleted by administering para-cholorophenylalanine (PCPA, 150 mg/kg, IP.) to rats 72 h and 48 h prior to the swim test. Fluoxetine (10 mg/kg, SC) or desipramine (10 mg/kg, SC) was given three times over a 24-h period prior to the FST. Behavioral responses, including immobility, swimming and climbing, were counted during the 5-min test.
Pretreatment with PCPA blocked fluoxetine-induced reduction in immobility and increase in swimming behavior during the FST. In contrast, PCPA pretreatment did not interfere with the ability of desipramine to reduce immobility and increase climbing behavior.
Depletion of serotonin prevented the behavioral effects of the selective serotonin reuptake inhibitor fluoxetine in the rat FST. Furthermore, depletion of serotonin had no impact on the behavioral effects induced by the selective norepinephrine reuptake inhibitor, desipramine. The effects of antidepressant drugs on FST-induced immobility may be exerted by distinguishable contributions from different neurotransmitter systems.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>10591883</pmid><doi>10.1007/s002130051156</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacologia, 1999-11, Vol.147 (2), p.162-167 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_proquest_miscellaneous_69346455 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Antidepressants Antidepressive Agents - therapeutic use Behavior Biological and medical sciences Climbing Desipramine Desipramine - therapeutic use Drugs Extracellular levels Fenclonine Fluoxetine Fluoxetine - therapeutic use Male Medical sciences Motor Activity - drug effects Neuropharmacology Norepinephrine Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Sprague-Dawley selective norepinephrine reuptake inhibitors selective serotonin reuptake inhibitors Serotonin Serotonin - physiology Serotonin Antagonists Serotonin uptake inhibitors Stress, Physiological - drug therapy Swimming Swimming behavior |
title | Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A38%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serotonergic%20mediation%20of%20the%20effects%20of%20fluoxetine,%20but%20not%20desipramine,%20in%20the%20rat%20forced%20swimming%20test&rft.jtitle=Psychopharmacologia&rft.au=PAGE,%20Michelle%20E&rft.date=1999-11-01&rft.volume=147&rft.issue=2&rft.spage=162&rft.epage=167&rft.pages=162-167&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s002130051156&rft_dat=%3Cproquest_cross%3E3117814666%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3117814666&rft_id=info:pmid/10591883&rfr_iscdi=true |